Consistently with these data, in our prospective cohort, BAL IL-1β showed potential in discriminating microbiologically confirmed VAP within a larger population of patients with VAP suspicion, with 81.5% sensitivity and 50% specificity at the cut-off point of 7.9 pg/ml. The gene discussed is IL1B; the disease is ventilator-associated pneumonia.